“The distinction between exploratory and confirmatory research cannot be important per se, because it implies that the time at which things are said is important”

This is Jessica. Andrew recently blogged in response to an article by McDermott arguing that pre-registration has costs like being unfair to junior scholars. I agree with his view that pre-registration can be a pre-condition for good science but not … Continue reading

The worst of both worlds: A comparative analysis of errors in learning from data in psychology and machine learning

This is Jessica. In a paper to appear at AIES 2022, Sayash Kapoor, Priyanka Nanayakkara, Arvind Narayanan, and Andrew and I write: Recent arguments that machine learning (ML) is facing a reproducibility and replication crisis suggest that some published claims … Continue reading

Not-so-obviously heuristic-proof reforms to statistical communication

This is Jessica. I’ve subscribed to aspects of the “estimation” movement–the move toward emphasizing magnitude and uncertainty of effects and testing multiple hypotheses rather than NHST–for awhile, having read this blog for years and switched over to using Bayesian stats … Continue reading

“When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?”

Javier Benítez pointed me to this JAMA article by Paul Young, Christopher Nickson, and Anders Perner, “When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?”, which begins: Understanding whether the results of a randomized clinical trial (RCT) are … Continue reading